|Defosfamide||DEHP||Dehydroacetic Acid||Dehydroascorbic Acid||Dehydrocholic Acid|
|Systematic (IUPAC) name|
|Metabolism||By plasma esterases, to active metabolite|
|Half-life||1.1–1.9 hours (metabolite)|
|Excretion||Renal (70%) and fecal (30%)|
|Mol. mass||441.517 g/mol|
|(what is this?)|
Deflazacort is a glucocorticoid used as an anti-inflammatory and immunosuppressant.
Deflazacort is an inactive prodrug which is metabolized rapidly to the active drug 21-desacetyldeflazacort. Its potency is around 70–90% that of prednisone.
It is sold in the United Kingdom by Shire under the trade name Calcort; in Brazil as Cortax, Decortil, and Deflanil; in India as MOAID, DFZ, Decotaz, and DefZot; in Panama as Zamen, Spain as Zamene and in Honduras as Flezacor. It is not available in the United States.